• In the past week, Rare Breed announced its official launch at Chewy, expanding nationwide access to its simple-ingredient beef and pork dog treats in multiple pack sizes while continuing donations to shelters and adoption-focused initiatives.
• A day earlier, Chewy reported first-quarter 2026 results showing higher sales of US$3,357.2 million and increased net income of US$94.8 million, underscoring the growing importance of its recurring Autoship program and pet health ecosystem.
• Next, we’ll examine how Chewy’s lowered 2026 revenue outlook amid softer pet spending affects this Autoship- and health-focused investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 49 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Chewy Investment Narrative Recap

To own Chewy, you need to believe its Autoship subscriptions and growing pet health ecosystem can offset softer pet spending and justify its premium valuation. The key near term catalyst is whether recurring Autoship revenue and pet health services can keep growing despite a weaker consumer backdrop, while the biggest risk is that slower customer growth and reduced 2026 sales guidance signal a more prolonged demand reset. The Rare Breed launch is directionally positive but not a material swing factor.

The most relevant update here is Chewy’s first quarter 2026 earnings, where sales rose to US$3,357.2 million and net income increased to US$94.8 million. These results highlight how central Autoship and pet health have become to Chewy’s thesis at a time when management has lowered 2026 revenue guidance amid softer pet spending, putting added pressure on these recurring and higher margin initiatives to carry the growth and profitability story.

Yet against this, investors should also be aware of the risk that Chewy’s heavy reliance on Autoship and slower active customer growth could...

Chewy’s narrative projects $15.9 billion revenue and $622.1 million earnings by 2029. This requires 8.0% yearly revenue growth and about a $399 million earnings increase from $222.8 million today.

Uncover how Chewy's forecasts yield a $39.85 fair value, a 119% upside to its current price.

Exploring Other Perspectives

Before this pullback, the most optimistic analysts were assuming Chewy could reach about US$16.5 billion in revenue and around US$683.7 million in earnings by 2029, which is far more upbeat than consensus and assumes pet health and Autoship loyalty programs both scale faster and more profitably than many expect, so as you weigh today’s weaker pet spending and guidance cut, it is worth asking whether you agree with that more aggressive story or see things very differently.

Explore 4 other fair value estimates on Chewy - why the stock might be worth over 3x more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Chewy research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Chewy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Chewy's overall financial health at a glance.

Searching For A Fresh Perspective?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Find 45 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.